REVIEU - A multinational, retrospective, observational drug utilisation study of REVOLADE™ (eltrombopag) In selected countries in the European Union (201108)

First published 30/06/2014

Last updated 02/07/2024

EU PAS number:

EUPAS6969

Study

Finalised

Documents

Study protocol

Initial protocol

weukbre7133-protocol-redact

English (1.49 MB - PDF) View document

Updated protocol

gsk-201108-protocol-redact

First published: 22/02/2024

English (1.86 MB - PDF) View document

Study results

gsk-201108-clinical-study-report-redact

English (9.63 MB - PDF) View document

Study report

Other information

Secondary tabs